Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,362 | 153 | 92.9% |
| Education | $256.28 | 3 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,240 | 59 | $0 (2023) |
| Janssen Biotech, Inc. | $846.75 | 38 | $0 (2024) |
| Lilly USA, LLC | $718.90 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $198.91 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $171.16 | 5 | $0 (2024) |
| PFIZER INC. | $139.14 | 4 | $0 (2019) |
| Almirall LLC | $130.49 | 1 | $0 (2019) |
| UCB, Inc. | $38.20 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $35.02 | 2 | $0 (2019) |
| Organogenesis Inc. | $33.86 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $724.06 | 31 | Janssen Biotech, Inc. ($257.82) |
| 2023 | $684.95 | 27 | Janssen Biotech, Inc. ($294.23) |
| 2022 | $432.02 | 20 | Lilly USA, LLC ($234.16) |
| 2021 | $308.48 | 28 | AbbVie Inc. ($149.73) |
| 2020 | $38.83 | 2 | AbbVie Inc. ($23.04) |
| 2019 | $319.16 | 11 | Almirall LLC ($130.49) |
| 2018 | $548.19 | 22 | AbbVie, Inc. ($448.59) |
| 2017 | $562.16 | 15 | AbbVie, Inc. ($466.02) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Organogenesis Inc. | PURAPLY AM (Device) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: WOUND CARE | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $87.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Immunology | ||||||
| 05/20/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $56.00 | General |
| Category: Immunology | ||||||
| 05/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.61 | General |
| Category: Immunology | ||||||
| 04/22/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/01/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $68.99 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,581 | 3,010 | $350,529 | $72,530 |
| 2022 | 17 | 1,848 | 3,544 | $400,913 | $86,039 |
| 2021 | 17 | 1,453 | 2,973 | $357,412 | $77,466 |
| 2020 | 18 | 1,632 | 3,267 | $371,621 | $75,204 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 377 | 500 | $92,750 | $22,018 | 23.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 355 | 479 | $66,461 | $17,277 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 122 | 144 | $37,901 | $9,120 | 24.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 36 | 37 | $23,837 | $4,720 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 84 | 84 | $19,089 | $4,231 | 22.2% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 149 | 177 | $37,701 | $3,325 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $10,765 | $2,838 | 26.4% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2023 | 18 | 19 | $12,355 | $2,245 | 18.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 279 | 1,398 | $17,825 | $1,967 | 11.0% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Facility | 2023 | 17 | 20 | $11,535 | $1,790 | 15.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 54 | 56 | $6,390 | $1,192 | 18.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Facility | 2023 | 11 | 11 | $5,792 | $655.52 | 11.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 26 | 31 | $3,511 | $485.77 | 13.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 11 | 12 | $2,853 | $368.07 | 12.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 11 | 11 | $1,766 | $298.64 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 389 | 523 | $97,017 | $23,834 | 24.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 395 | 512 | $71,040 | $19,146 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 159 | $41,849 | $10,695 | 25.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 135 | 135 | $30,679 | $7,389 | 24.1% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 176 | 206 | $43,878 | $3,793 | 8.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 41 | 41 | $14,237 | $3,786 | 26.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Facility | 2022 | 26 | 27 | $17,395 | $3,487 | 20.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 319 | 1,684 | $21,471 | $2,574 | 12.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Facility | 2022 | 32 | 36 | $12,096 | $2,283 | 18.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2022 | 17 | 18 | $11,705 | $2,211 | 18.9% |
About Dr. Nathan Miller, DO
Dr. Nathan Miller, DO is a Dermatology healthcare provider based in Klamath Falls, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1265728166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Miller, DO has received a total of $3,618 in payments from pharmaceutical and medical device companies, with $724.06 received in 2024. These payments were reported across 156 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,362).
As a Medicare-enrolled provider, Miller has provided services to 6,514 Medicare beneficiaries, totaling 12,794 services with total Medicare billing of $311,238. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Klamath Falls, OR
- Active Since 06/20/2011
- Last Updated 08/07/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265728166
Products in Payments
- Humira (Biological) $988.75
- TALTZ (Drug) $519.47
- TREMFYA (Drug) $511.83
- REMICADE (Biological) $303.32
- SKYRIZI (Biological) $145.03
- DUPIXENT (Biological) $139.50
- EUCRISA (Drug) $139.14
- Sotyktu (Drug) $137.15
- Seysara (Drug) $130.49
- OLUMIANT (Drug) $75.97
- LIBTAYO (Biological) $59.41
- HUMIRA (Biological) $39.84
- STELARA (Biological) $31.60
- RINVOQ (Biological) $27.12
- AMELUZ (Drug) $25.35
- ODOMZO (Drug) $21.72
- Cimzia (Drug) $20.96
- PURAPLY AM (Device) $19.82
- COSENTYX (Biological) $18.63
- HYRIMOZ (Biological) $18.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.